Method for treating aneurysms

Information

  • Patent Grant
  • 8915952
  • Patent Number
    8,915,952
  • Date Filed
    Friday, October 15, 2004
    20 years ago
  • Date Issued
    Tuesday, December 23, 2014
    10 years ago
  • Inventors
  • Original Assignees
  • Examiners
    • McEvoy; Thomas
    • Szpira; Julie A
    Agents
    • Hill; James W.
    • Smith; Nathan
    • McDermott Will & Emery LLP
Abstract
A method for treating a bifurcation aneurysm, the aneurysm having an aneurysm neck, by positioning a first mechanically expandable device in a first bifurcation branch proximate to the aneurysm neck; positioning a second mechanically expandable device in a second bifurcation branch proximate to the aneurysm neck; and expanding the mechanically expandable devices to constrict the aneurysm neck such that blood circulation to the bifurcation aneurysm is reduced.
Description
RELATED APPLICATIONS

This application is a U.S. National Phase of International Application No. PCT/SG2004/000338, filed Oct. 15, 2004, designating the U.S. and published in English on Oct. 13, 2005 as WO 2005/094725, which claims the benefit of Singapore Application No. 200401735-6, filed Mar. 31, 2004.


TECHNICAL FIELD

The invention concerns a method for treating bifurcation or trifurcation aneurysms. In particular, the method is suitable for bifurcation or trifurcation aneurysms with wide aneurysm necks.


BACKGROUND OF THE INVENTION

An aneurysm is a bulge or a weakening of a wall of an artery. An aneurysm usually occurs where one main blood vessel splits into two (bifurcation) or three smaller vessels (trifurcation). Bifurcation aneurysms account for approximately 35% of all cases of intracranial hemorrhagic disease.


Aneurysms may burst and cause bleeding into a covering around the brain called the subarachnoid space. This is referred to as a subarachnoid hemorrhage. Subarachnoid hemorrhage secondary to a ruptured aneurysm causes a severe headache.


Therefore, there is a desire for minimally invasive, less traumatic methods to treat bifurcation and trifurcation aneurysms.


SUMMARY OF THE INVENTION

In a first preferred aspect, there is provided a method for treating a bifurcation aneurysm, the aneurysm having an aneurysm neck, the method comprising:

    • positioning a first mechanically expandable device in a first bifurcation branch proximate to the aneurysm neck;
    • positioning a second mechanically expandable device in a second bifurcation branch proximate to the aneurysm neck; and
    • expanding the mechanically expandable devices to constrict the aneurysm neck such that blood circulation to the bifurcation aneurysm is reduced.


The aneurysm neck may be constricted such that blood circulation to the aneurysm is completely interrupted.


The mechanically expandable devices may be stents.


The stents may be mechanically expanded such that blood circulation to the bifurcation aneurysm via the aneurysm neck may be occluded.


The aneurysm may be reduced further in size by deploying gels or using coils. Where the aneurysm neck is wide, coils or securing glues may be deployed inside the aneurysm to reduce blood circulation inside the aneurysm. An aneurysm neck may be wide if the ratio of the diameter of the dome of the aneurysm to the width of the aneurysm neck is less than two.


The stents may be balloon expandable or self-expandable.


The stents may have markers to facilitate precise positioning in the branches. The markers may be placed at the distal and proximal ends of the stents. The markers may be radiopaque. The markers may be made from gold or platinum.


The stents may be positioned in the branches sequentially.


The stents may be expanded at the same time. Alternatively, the stents may be expanded sequentially.


The stent may be tapered towards the distal end of the stent. The stent may have a trapezoidal longitudinal cross-section. The stent may have proximal end struts that are elongated relative to the remaining struts.


The first stent may be positioned partially within the first bifurcation branch such that a portion of the proximal end of the first stent is not introduced within the first bifurcation branch.


The second stent may be positioned partially within the second bifurcation branch such that a portion of the proximal end of the second stent is not introduced within the second bifurcation branch.


A balloon of a balloon catheter may be used to expand the stent during deployment. The balloon may be tapered such that the proximal end of the stent is expanded first during deployment. Advantageously, this allows the aneurysm neck to be bridged with greater effectiveness.


The balloon may be made of soft durometer thin nylon or silicon.


The first stent may be expanded by a first balloon and the second stent may be expanded by a second balloon. The first and second balloons may be on a single shaft of a balloon catheter. The stents may be expanded at the same time during deployment.


Additional angioplasty balloon expansion may be used to secure the deployment of the stents.


The stents may be connected by a membrane for obstructing blood circulation to the bifurcation aneurysm. The membrane may comprise at least one layer of an elastomeric polymer. The membrane may comprise receptacles for carrying drugs or reagents for subsequent release after the stents are deployed. The drugs or reagents may include substances that reduce the thrombogenic, inflammatory or smooth muscle cell proliferative response of the vessel to the implantable medical devices. For example, cell inhibitors can be delivered in order to inhibit smooth muscle cells proliferation. In intracranial or some other applications fibrin sealants can be used and delivered to seal aneurysm neck and provide fibroblasts and endothelial cells growth. Specific examples of drugs or reagents may include heparin, phosporylcholine, albumin, dexamethasone, paclitaxel and vascular endothelial growth factor (VEGF).


In a second aspect, there is provided a method for treating a trifurcation aneurysm, the aneurysm having an aneurysm neck, the method comprising:

    • positioning a first mechanically expandable device in a first trifurcation branch proximate to the aneurysm neck;
    • positioning a second mechanically expandable device in a second trifurcation branch proximate to the aneurysm neck;
    • positioning a third mechanically expandable device in a third trifurcation branch proximate to the aneurysm neck; and
    • expanding the mechanically expandable devices to constrict the aneurysm neck such that blood circulation to the trifurcation aneurysm is reduced.


The first mechanically expandable device may be positioned partially within the first trifurcation branch such that a portion of the proximal end of the first mechanically expandable device is not introduced within the first trifurcation branch.


The second mechanically expandable device may be positioned partially within the second trifurcation branch such that a portion of the proximal end of the second mechanically expandable device is not introduced within the second trifurcation branch.


The third mechanically expandable device may be positioned partially within the third trifurcation branch such that a portion of the proximal end of the third mechanically expandable device is not introduced within the third trifurcation branch.


In a third aspect, there is provided a system for treating a bifurcation aneurysm, the aneurysm having an aneurysm neck, the system comprising:

    • a first mechanically expandable device positioned in a first bifurcation branch proximate to the aneurysm neck;
    • a second mechanically expandable device positioned in a second bifurcation branch proximate to the aneurysm neck; and
    • wherein the mechanically expandable devices are expanded to constrict the aneurysm neck such that blood circulation to the bifurcation aneurysm is reduced.


In a fourth aspect, there is provided a system for treating a trifurcation aneurysm, the aneurysm having an aneurysm neck, the system comprising:

    • a first mechanically expandable device positioned in a first trifurcation branch proximate to the aneurysm neck;
    • a second mechanically expandable device positioned in a second trifurcation branch proximate to the aneurysm neck;
    • a third mechanically expandable device positioned in a third trifurcation branch proximate to the aneurysm neck; and
    • wherein the mechanically expandable devices are expanded to constrict the aneurysm neck such that blood circulation to the trifurcation aneurysm is reduced.


In a fifth aspect, there is provided a mechanically expandable device for treating a bifurcation or trifurcation aneurysm, the aneurysm having an aneurysm neck, the device comprising:

    • a generally tubular structure having an exterior surface defined by a plurality of interconnected struts having interstitial spaces therebetween, said generally tubular structure expandable from a first position to a second position, and said tubular structure is expanded radially outwardly to the second position such that the exterior surface of said structure engages with the inner surface of a bifurcation or trifurcation branch so as to maintain a fluid pathway through said branch and to constrict the aneurysm neck such that blood circulation to the aneurysm is reduced;
    • wherein a proximal portion of the struts are elongated relative to the remaining struts such that the device is tapered towards its distal end after deployment in the branch.


In a sixth aspect, there is provided a balloon for expanding a mechanically expandable device for treating a bifurcation or trifurcation aneurysm, the balloon being connected to a balloon catheter for inflation, and the device comprising a interconnected struts at its proximal end that are elongated relative to the remaining struts of the device such that the device is tapered towards its distal end after deployment in a bifurcation or trifurcation branch;

    • wherein the balloon is tapered towards its distal end after inflation, and the inflation of the balloon causes the elongated struts of the device to expand at a greater rate than the remaining struts for constricting the aneurysm neck such that blood circulation to the aneurysm is reduced.


The balloon may be a first balloon used in combination with a second balloon to expand a second mechanically expandable device in another bifurcation or trifurcation branch. The first balloon and second balloon may be inflated together via a single balloon catheter





BRIEF DESCRIPTION OF THE DRAWINGS

An example of the invention will now be described with reference to the accompanying drawings, in which:



FIG. 1 is a pictorial representation of a bifurcation aneurysm;



FIG. 2 is a pictorial representation of a stent deployed in a bifurcation branch;



FIG. 3 is a pictorial representation of stents deployed in both bifurcation branches;



FIG. 4 is a pictorial representation of a reduction of blood circulation to the bifurcation aneurysm when the stents are expanded;



FIG. 5 is a pictorial representation of a tapered balloon to deploy the stent in a bifurcation branch;



FIG. 6 is a pictorial representation of a tapered stent being deployed by a tapered balloon in a bifurcation branch;



FIG. 7 is a pictorial representation of tapered stents deployed in both bifurcation branches;



FIG. 8 is a pictorial representation of a tapered stent with elongated end struts when deployed;



FIG. 9 is a pictorial representation of a tapered stent with elongated end struts before deployment;



FIG. 10 is a pictorial representation of stents connected by a patch deployed in both bifurcation branches;



FIG. 11 is a pictorial representation of stents with markers connected by a membrane deployed in both bifurcation branches;



FIG. 12 is a pictorial representation of a tapered stent with elongated end struts and a marker before deployment;



FIG. 13 is a pictorial representation of tapered stents with markers in both bifurcation branches being expanded by two connected tapered balloons;



FIG. 14 is a pictorial representation of tapered stents with markers deployed in both bifurcation branches; and



FIG. 15 is a pictorial representation of coils deployed in the aneurysm in addition to tapered stents with markers deployed in both bifurcation branches.





DETAILED DESCRIPTION OF THE DRAWINGS

Referring to FIG. 1, a method for treating a bifurcation aneurysm 10 is shown. The aneurysm 10 has an aneurysm neck 11 where blood passes from a main artery 15 to the aneurysm 10. The aneurysm 10 is located at the end of the main artery 15 where it diverges into two bifurcation branches 12, 13. A first stent 20 is positioned in a first bifurcation branch 12 proximate to the aneurysm neck 11 as shown in FIG. 2. Next, a second stent 21 is positioned in a second bifurcation branch 13 proximate to the aneurysm neck 11 as shown in FIG. 3. The stents 12, 13 are expanded to constrict the aneurysm neck 11 such that blood circulation to the aneurysm 10 is reduced. In a bifurcation branch 12, 13, the side of the branch wall 12, 13 opposing the aneurysm neck 11 is more rigid relative to the branch wall 12, 13 adjacent to the aneurysm neck 11. Thus, when the stent 20, 30 is expanded, the majority of the expansion force is directed towards the branch wall 12, 13 adjacent to the aneurysm neck 11 which begins to constrict the aneurysm neck 11. Even if the aneurysm neck 11 is partially constricted, blood circulation to the aneurysm 10 is reduced. This eventually leads to the aneurysm 10 drying out from a reduction in blood circulation as shown in FIG. 4.


Intracranial stents 20, 30 are designed to be very flexible, and have a low profile (0.033″ to 0.034″ or even less as crimped onto delivery catheter) and thin wall (0.0027″ to 0.0028″). The intracranial stents 20, 30 feature low deployment pressure (3 to 4 atmospheres) and do not necessarily have the highest possible radial strength because there is no need for high strength in intracranial applications. In one example, the stents 20, 30 are made from platinum/iridium/tungsten alloys.


Stents 20, 30 are a generally tubular structure having an exterior surface defined by a plurality of interconnected struts 32 having interstitial spaces there between. The generally tubular structure is expandable from a first position, wherein the stent 20, 30 is sized for intravascular insertion, to a second position, wherein at least a portion of the exterior surface of the stent contacts the vessel wall 12, 13. The expansion of the stent 20, 30 is accommodated by flexing and bending of the interconnected struts 32 throughout the generally tubular structure. It is contemplated that many different stent designs can be produced. A myriad of strut patterns are known for achieving various design goals such as enhancing strength, maximizing the expansion ratio or coverage area, enhancing longitudinal flexibility or longitudinal stability upon expansion. One pattern may be selected over another in an effort to optimize those parameters that are of particular importance for a particular application.


In one example, the stent 20, 30 comprises stent struts 32 of a ring, ring connectors, and end markers 34. The stents 100 are made of multiple circumstantial rings, where the ring connectors connect two or three adjacent rings to hold the rings in place. In another example, a self-expanding stent 20, 30 is made of wires/ribbons. While a self-expanding stent may have many designs, one specific stent 20, 30 has a typical braided pattern with welded ends. The stent 20, 30 is designed such that it is relatively flexible along its longitudinal axis to facilitate delivery through tortuous body lumens, but is sufficiently stiff and stable radially in an expanded condition to maintain the patency of a body lumen, such as an artery or bifurcation/trifurcation branch 12, 13 when implanted therein. When a tubular stent 20, 30 is fully expanded to its deployed diameter, the latticework of struts 32 takes on a shape in which adjacent crests undergo wide separation, and portions of the struts 32 take on a transverse, almost fully lateral orientation relative to the longitudinal axis of the stent 20, 30. Such lateral orientation of a plurality of the struts 32 enables each fully opened cell to contribute to the firm mechanical support offered by the stent 20, 30 in its fully deployed position, to assure a rigid structure which is highly resistant to recoil of the vessel wall 12, 13 following stent deployment. It bears emphasis, however, that the configuration of this stent structure, while highly desirable, is illustrative only.


Referring to FIGS. 5 to 9, tapered stents 30, 31 are used to further enhance constriction of the aneurysm neck 11. For the delivery system, a tapered balloon 35 of a balloon catheter 36 expands the tapered stents 30, 31 by inflation, after the stents 30, 31 are placed into position in a respective bifurcation branch 12, 13. At the proximal end of the tapered stents 30, 31 there are elongated struts 33 to provide the tapering effect. The elongated struts 33 expand at a greater rate relative to the non-elongated struts 32. Also, tapered stents 30, 31 after deployment have a profile which conforms to the opening of the bifurcation branch 12, 13 from the main artery 15. FIG. 8 depicts a tapered stent 30 in an expanded state, typically when the stent 30 is deployed. FIG. 9 depicts the tapered stent 30 in a compressed state, typically during delivery via the balloon catheter 36.


The delivery system includes a guide wire lumen, a balloon inflating lumen, a connector, a balloon catheter shaft, and platinum marker bands on the catheter shaft (not shown). The guide wire lumen is used for introducing a guide wire in a balloon catheter 36, and the balloon inflating lumen is used for inflating the balloon 35 after the stent 20, 30 to be placed reaches its targeted location. The connector is used for separating the guide wire lumen and the balloon inflating lumen. The balloon catheter shaft carries the guide wire lumen and the balloon inflating lumen separately, with a typical length ranging 135 to 170 cm. The ring markers on the catheter shaft are used for showing the start of balloon tapers 35 and the edges of the stent 20, 30.


The balloon 35 is formed of suitable materials such as irradiated polyethylene, polyethylene terephthalate, polyvinylchloride, nylon, and copolymer nylons such as Pebax™. Other polymers may also be used. In order for the stent 20, 30 to remain in place on the balloon 35 during delivery to the desired site within a branch 12, 13, the stent 20, 30 is crimped onto the balloon 35.


In a preferred embodiment, the delivery of the stent 20, 30 is accomplished in the following manner. The stent 20, 30 is first mounted onto the inflatable balloon 35 on the distal extremity of the delivery catheter 36. The stent 20, 30 is mechanically crimped onto the exterior of the folded balloon 35. The catheter/stent assembly is introduced within vasculature through a guiding catheter. A guide wire is disposed across the diseased arterial section and then the catheter/stent assembly is advanced over a guide wire within the branch 12, 13 until the stent 20, 30 reaches the desired position. The balloon 35 of the catheter 36 is expanded, expanding the stent 20, 30 against the branch wall 12, 13. The expanded stent serves to hold open the artery after the catheter is withdrawn. Due to the formation of the stent 20, 30 from an elongated tube, the undulating component of the cylindrical elements of the stent 20, 30 is relatively flat in transverse cross-section, so that when the stent 20, 30 is expanded, the cylindrical elements are pressed against the wall of the branch 12, 13 and as a result do not interfere with the blood flow through the branch 12, 13. The cylindrical elements of the stent 20, 30 which are pressed into the wall of the branch 12, 13 is eventually covered with an endothelial cell layer which further minimizes blood flow interference. Furthermore, the closely spaced cylindrical elements at regular intervals provide uniform support for the wall of the branch 12, 13, and consequently are well adopted to take up and hold in place small flaps or dissections in the wall of the branch 12, 13.


As described earlier, a stent 20, 30 may be deployed by radial expansion under outwardly directed radial pressure exerted. For example by active inflation of a balloon 35 of a balloon catheter 36 on which the stent 20, 30 is mounted. Another deployment method may rely on the stent 20, 30 being self-expandable. In some instances, passive spring characteristics of a preformed elastic (that is, self-opening) stent 20, 30 serve the purpose. The stent 20, 30 is then expanded to engage the inner lining or inwardly facing surface of the vessel wall 12, 13 with sufficient resilience to allow some contraction but also with sufficient stiffness to largely resist the natural recoil of the vessel wall 12, 13.


For resilient or self-expanding stents 20, 30, they are deployed without dilation balloons 35. Self-expanding stents 20, 30 are pre-selected according to the diameter of the blood vessel, bifurcation/trifurcation branch 12, 13 or other intended fixation site. While stent deployment requires skill in stent positioning, such deployment does not require the additional skill of carefully dilating a balloon 35 to plastically expand the prosthesis to the appropriate diameter. Further, the self-expanding stent 20, 30 remains at least slightly elastically compressed after fixation, and has a restoring force which facilitates acute fixation. By contrast, a plastically expanded stent 20, 30 must rely on the restoring force of deformed tissue, or on hooks, barbs, or other independent fixation elements.


Referring to FIG. 15, in a further example, the aneurysm 10 is reduced further in size by deploying gels or using coils 50. If the aneurysm neck 11 is wide, coils 50 or securing glues (not shown) are deployed inside the aneurysm 10 to reduce blood circulation inside the aneurysm 10. An aneurysm neck 11 can be considered wide if the ratio of the diameter of the dome of the aneurysm 10 to the width of the aneurysm neck 11 is less than two.


Referring to FIG. 10, a pair of stents 20, 21 are joined together by a membrane 25. The membrane 25 obstructs blood circulation to the aneurysm 10. The stents 20, 21 are an open cell design and have a variable profile. Thus in addition to constriction of the aneurysm neck 11 by the stents 20, 21, the presence of the membrane 25 also obstructs blood circulation through the aneurysm neck 11 and may hasten the drying out of the aneurysm 10.


In one example, the membrane 25 may comprise one or more layers of an elastomeric polymer. The membrane 25 may comprise a first layer and a second layer. Many polymeric materials are suitable for making the layers of the membrane 25. One such material may be elastomeric polyurethane. Typically, one first layer is disposed onto the outer surface of a stent 20, 30.


In certain embodiments, the first layer is an independent membrane to mechanically cover and seal the aneurysm 10. In certain embodiments, the first and/or second layers may be made from biodegradable material as a drug or reagent carrier for sustained release.


The intermediate layer may be formed of a material which fuses to the first and second layers or attached to the first layer in a different manner. In certain embodiments, the intermediate layer may be merged with the first layer to form a single layer with recessions within the outer surface of the merged layer.


In one embodiment, the second and intermediate layers are made of biodegradable material that contains drugs or reagents for immediate or sustained controlled release. After biodegradable material has degraded over time, the membrane 25 is still in tact to provide vessel support. The second layer may be made from a polymeric material.


The polymeric layers of the membrane 25 may also be made from a material selected from the group consisting of fluoropolymers, polyimides, silicones, polyurethanes, polyurethanes ethers, polyurethane esters, polyurethaneureas and mixtures and copolymers thereof. Biodegradable polymeric materials can also be used.


Adhering, laminating, suturing or otherwise bonding fusible polymeric layers may be conducted. The fusion of the polymeric layers may be achieved by various techniques such as heat-sealing, solvent bonding, adhesive bonding or use of coatings.


The membrane 25 may further comprise pockets (not shown) serving as receptacles for drugs or reagents so that the drugs or reagents may be delivered into vascular systems. The membrane 25 may cover a part of a stent 20, 30, where the size of the membrane 25 may be varied in accordance with any specific application. In one extreme, the membrane 25 may cover the whole outer surface of a stent 20, 30. Thus, the membrane 25 may be in any shape or size. A drug or reagent can be injected in the form of a gel, liquid or powder into receptacles of the pockets. Alternatively the drug or reagent can be supplied in a powder which has been formed into a solid tablet positioned in the receptacles. Such tablets would gradually dissolve after implantation. The drugs or reagents include substances that reduce the thrombogenic, inflammatory or smooth muscle cell proliferative response of the vessel to the implantable medical devices. For example, cell inhibitors can be delivered in order to inhibit smooth muscle cells proliferation. In intracranial or some other applications fibrin sealants can be used and delivered to seal aneurysm neck and provide fibroblasts and endothelial cells growth. Specific examples of drugs or reagents may include heparin, phosporylcholine, albumin, dexamethasone, paclitaxel and vascular endothelial growth factor (VEGF).



FIGS. 11 and 12 show stents 20, 21, 30, 31 with markers 34. The markers 34 improve visibility as they are radiopaque and may be made from gold or platinum. The markers 34 facilitate precise positioning and orientation of the stents 20, 30 during deployment in the branches 12, 13. The markers 34 may be end markers and are usually placed at the distal and proximal ends of the stents 20, 30. The drawings show a disc shaped marker. However, the shape is not critical so long as the marker 34 can be used to improve visibility of the stent 20, 30. The markers may be center markers that are special type platinum star-shaped markers to assist in precise indication and alignment of the stents 20, 30 in relation to the aneurysm neck 11 and allow further operations with the aneurysm 10. Then, the markers located around the middle of the stent 20, 30. The center markers assist in locating an aneurysm opening during an implantation operation. The center markers can be made of the same material and have the same shape as the end markers.



FIG. 13 shows tapered stents 30, 31 with markers 34 during deployment. The tapered stents 30, 31 are expanded by two balloons 35 via a single balloon catheter 36. After the tapered stents 30, 31 have been expanded the balloons 35 are deflated and the catheter 36 is retracted as shown in FIG. 14.


Although a bifurcation aneurysm 10 has been described, it is envisaged that the present invention may be used for trifurcation aneurysms and the like.


It will be appreciated by persons skilled in the art that numerous variations and/or modifications may be made to the invention as shown in the specific embodiments without departing from the scope or spirit of the invention as broadly described. The present embodiments are, therefore, to be considered in all respects illustrative and not restrictive.

Claims
  • 1. A mechanically expandable device for treating a bifurcation or trifurcation aneurysm, the aneurysm having an aneurysm neck, the device comprising: a generally tubular structure having a proximal end, a distal end, and an exterior surface defined by a plurality of interconnected struts forming a series of peaks and valleys having interstitial spaces therebetween, said generally tubular structure expandable from a first position to a second position, and said tubular structure is configured to expand radially outwardly to the second position such that the exterior surface of said structure engages with the inner surface of a bifurcation or trifurcation branch so as to maintain a fluid pathway through said branch and to constrict the aneurysm neck such that blood circulation to the aneurysm is reduced;wherein, in the second position, the tubular structure has a cylindrical portion and a tapered portion, the cylindrical portion having a substantially uniform diameter along its longitudinal length, the tapered portion flaring outwardly from the cylindrical portion to the proximal end of the tubular structure, the cylindrical portion comprising a plurality of rings interconnected by a plurality of interconnecting struts, the tapered portion comprising a distalmost ring, a proximalmost ring, and a distal interconnecting strut extending between a peak of the distalmost ring and a valley of the proximalmost ring, the proximalmost ring having a longer longitudinal length than any of the rings in the cylindrical portion, the distal interconnecting strut having a longer longitudinal length than any of the interconnecting struts in the cylindrical portion, and each of the plurality of rings in the cylindrical portion, the distalmost ring, and the proximalmost ring encircling a longitudinal axis of the tubular structure.
  • 2. The device according to claim 1, wherein the tubular structure comprises a self-expanding structure.
  • 3. The device according to claim 1, wherein the tubular structure comprises a plastically deformable structure.
  • 4. The device according to claim 1, wherein the struts comprise at least one material selected from the group consisting of: platinum, iridium, and tungsten.
  • 5. The device according to claim 1, wherein the struts are constructed and arranged in a pattern to achieve, when expanded, one or more of enhanced strength, increased expansion ratio, increased coverage area, enhanced longitudinal flexibility, and enhanced longitudinal stability.
  • 6. The device according to claim 1, wherein the device has a longitudinal axis and wherein at least two of the struts comprise a portion configured to transition to a lateral or near lateral orientation relative to the longitudinal axis when the device is expanded.
  • 7. The device according to claim 1, further comprising at least one marker.
  • 8. The device according to claim 7, wherein the at least one marker comprises a radiopaque marker.
  • 9. The device according to claim 7, wherein the at least one marker is positioned at an end portion of the device or a middle portion of the device.
  • 10. The device according to claim 7, wherein the at least one marker has a disk shape or a star shape.
  • 11. The device according to claim 1, further comprising a coupling strut extending between a valley of the proximalmost ring and a peak of a ring of the cylindrical portion.
  • 12. The device according to claim 11, wherein the coupling strut and the distal interconnecting strut extend along a common, substantially linear path along the exterior surface of the tubular structure.
  • 13. The device according to claim 11, further comprising a proximal interconnecting strut extending between the peak of the cylindrical portion ring and a valley of a second ring of the cylindrical portion, the second ring being proximal to the cylindrical portion ring.
  • 14. The device according to claim 13, wherein the distal interconnecting strut, the proximal interconnecting strut, and the coupling strut extend along a common, substantially linear path along the exterior surface of the tubular structure.
  • 15. The device according to claim 11, wherein the coupling strut and the distal interconnecting strut extend along different, substantially linear paths along the exterior surface of the tubular structure.
  • 16. The device according to claim 1, wherein the distal interconnecting strut longitudinal length is greater than a longitudinal length of the distalmost ring and the longitudinal length of the proximalmost ring.
  • 17. The device according to claim 1, wherein the distalmost ring has a longer longitudinal length than any of the rings in the cylindrical portion.
  • 18. The device according to claim 1, further comprising a second distal interconnecting strut extending between a second peak of the distalmost ring and a second valley of the proximalmost ring, the second distal interconnecting strut being circumferentially spaced apart from the distal interconnecting strut.
  • 19. The device according to claim 18, further comprising first and second coupling struts extending between respective first and second valleys of the proximalmost ring and respective first and second peaks of the cylindrical portion ring.
  • 20. The device according to claim 19, wherein the distal interconnecting strut and the first coupling strut extend along a first common, substantially linear path along the exterior surface of the tubular structure, and wherein the second distal interconnecting strut and the second coupling strut extend along a second common, substantially linear path along the exterior surface of the tubular structure.
Priority Claims (1)
Number Date Country Kind
200401735-6 Mar 2004 SG national
PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/SG2004/000338 10/15/2004 WO 00 9/29/2006
Publishing Document Publishing Date Country Kind
WO2005/094725 10/13/2005 WO A
US Referenced Citations (182)
Number Name Date Kind
4416028 Eriksson et al. Nov 1983 A
4503569 Dotter Mar 1985 A
5041441 Radin et al. Aug 1991 A
5234457 Anderson Aug 1993 A
5356423 Tihon et al. Oct 1994 A
5405377 Cragg Apr 1995 A
D359802 Fontaine Jun 1995 S
5421955 Lau et al. Jun 1995 A
5443458 Eury Aug 1995 A
5514154 Lau et al. May 1996 A
5562725 Schmitt et al. Oct 1996 A
5589563 Ward et al. Dec 1996 A
5601593 Freitag Feb 1997 A
5620763 House et al. Apr 1997 A
5630840 Mayer May 1997 A
5632840 Campbell May 1997 A
5639278 Dereume et al. Jun 1997 A
5700285 Myers et al. Dec 1997 A
D390957 Fontaine Feb 1998 S
5716393 Lindenberg et al. Feb 1998 A
5718973 Lewis et al. Feb 1998 A
5735893 Lau et al. Apr 1998 A
5744515 Clapper Apr 1998 A
5766238 Lau et al. Jun 1998 A
5769884 Solovay Jun 1998 A
5810870 Myers et al. Sep 1998 A
5843027 Stone et al. Dec 1998 A
5843172 Yan Dec 1998 A
5858556 Eckert et al. Jan 1999 A
5866217 Stenoien et al. Feb 1999 A
5902475 Trozera et al. May 1999 A
5925075 Myers et al. Jul 1999 A
5948018 Dereume et al. Sep 1999 A
5951599 McCrory Sep 1999 A
5993489 Lewis et al. Nov 1999 A
6001123 Lau Dec 1999 A
6010530 Goicoechea Jan 2000 A
6024765 Wallace et al. Feb 2000 A
6027811 Campbell et al. Feb 2000 A
6033435 Penn et al. Mar 2000 A
6036720 Abrams et al. Mar 2000 A
6056775 Borghi et al. May 2000 A
6056776 Lau et al. May 2000 A
6066167 Lau et al. May 2000 A
6139564 Teoh Oct 2000 A
6140127 Sprague Oct 2000 A
6168610 Marin et al. Jan 2001 B1
6174328 Cragg Jan 2001 B1
6217607 Alt Apr 2001 B1
6240616 Yan Jun 2001 B1
6240948 Hansen, III et al. Jun 2001 B1
6248190 Stinson Jun 2001 B1
6258120 McKenzie et al. Jul 2001 B1
6270523 Herweck et al. Aug 2001 B1
6309367 Boock Oct 2001 B1
6312463 Rourke et al. Nov 2001 B1
6315791 Gingras et al. Nov 2001 B1
6371980 Rudakov et al. Apr 2002 B1
6409754 Smith et al. Jun 2002 B1
6416474 Penner et al. Jul 2002 B1
6436132 Patel et al. Aug 2002 B1
6451050 Rudakov et al. Sep 2002 B1
6451052 Burmeister et al. Sep 2002 B1
6454780 Wallace Sep 2002 B1
6485507 Walak et al. Nov 2002 B1
6488701 Nolting et al. Dec 2002 B1
6508832 Jalisi et al. Jan 2003 B1
6517571 Brauker et al. Feb 2003 B1
6524336 Papazolgou et al. Feb 2003 B1
6527802 Mayer Mar 2003 B1
6533905 Johnson et al. Mar 2003 B2
6547815 Myers Apr 2003 B2
6582461 Burmeister et al. Jun 2003 B1
6582652 Craig Jun 2003 B2
6602281 Klein Aug 2003 B1
6613072 Lau et al. Sep 2003 B2
6613074 Mitelberg et al. Sep 2003 B1
6623520 Jalisi Sep 2003 B2
6652574 Jayaraman Nov 2003 B1
D484979 Fontaine Jan 2004 S
6673108 Zilla et al. Jan 2004 B2
6676701 Rourke et al. Jan 2004 B2
6679910 Granada Jan 2004 B1
6695833 Frantzen Feb 2004 B1
6695876 Marotta et al. Feb 2004 B1
6699276 Sogard et al. Mar 2004 B2
6706061 Fischell et al. Mar 2004 B1
6719782 Chuter Apr 2004 B1
6736844 Glatt et al. May 2004 B1
6796997 Penn et al. Sep 2004 B1
6802851 Jones et al. Oct 2004 B2
6805706 Solovay et al. Oct 2004 B2
6818013 Mitelberg et al. Nov 2004 B2
6821293 Pinchasik Nov 2004 B2
6855154 Abdel-Gawwad Feb 2005 B2
6899727 Armstrong et al. May 2005 B2
6936055 Ken et al. Aug 2005 B1
6949116 Solymar et al. Sep 2005 B2
6979349 Dang et al. Dec 2005 B1
7029493 Majercak et al. Apr 2006 B2
7041127 Ledergerber May 2006 B2
7041129 Rourke et al. May 2006 B2
7060091 Killion et al. Jun 2006 B2
7105019 Hojeibane Sep 2006 B2
7125419 Sequin et al. Oct 2006 B2
7153322 Alt Dec 2006 B2
7169174 Fischell et al. Jan 2007 B2
7258697 Cox et al. Aug 2007 B1
D553746 Fliedner Oct 2007 S
D553747 Fliedner Oct 2007 S
7306622 Jones et al. Dec 2007 B2
7311726 Mitelberg et al. Dec 2007 B2
7686846 Laborde et al. Mar 2010 B2
8075609 Penn et al. Dec 2011 B2
20020035394 Fierens et al. Mar 2002 A1
20020042646 Wall Apr 2002 A1
20020045931 Sogard et al. Apr 2002 A1
20020049495 Kutryk et al. Apr 2002 A1
20020065546 Machan et al. May 2002 A1
20020111543 Penner et al. Aug 2002 A1
20020133224 Bajgar et al. Sep 2002 A1
20020151968 Zilla et al. Oct 2002 A1
20030018294 Cox Jan 2003 A1
20030060782 Bose et al. Mar 2003 A1
20030093111 Ken et al. May 2003 A1
20030171801 Bates Sep 2003 A1
20030229286 Lenker Dec 2003 A1
20030229393 Kutryk et al. Dec 2003 A1
20030233141 Israel Dec 2003 A1
20040029268 Colb et al. Feb 2004 A1
20040087998 Lee et al. May 2004 A1
20040116998 Erbel et al. Jun 2004 A1
20040138736 Obara Jul 2004 A1
20040170685 Carpenter et al. Sep 2004 A1
20040172121 Eidenschink et al. Sep 2004 A1
20040186562 Cox Sep 2004 A1
20040193206 Gerberding et al. Sep 2004 A1
20040204754 Kaplan et al. Oct 2004 A1
20050010281 Yodfat et al. Jan 2005 A1
20050043787 Kutryk et al. Feb 2005 A1
20050075716 Yan Apr 2005 A1
20050096725 Pomeranz et al. May 2005 A1
20050124896 Richter et al. Jun 2005 A1
20050137677 Rush Jun 2005 A1
20050137680 Ortiz et al. Jun 2005 A1
20050154447 Goshgarian Jul 2005 A1
20050154448 Cully et al. Jul 2005 A1
20050171593 Whirley et al. Aug 2005 A1
20050267568 Berez et al. Dec 2005 A1
20050283220 Gobran et al. Dec 2005 A1
20060020322 Leynov et al. Jan 2006 A1
20060036311 Nakayama et al. Feb 2006 A1
20060106421 Teoh May 2006 A1
20060121080 Lye et al. Jun 2006 A1
20060136037 DeBeer et al. Jun 2006 A1
20060142849 Killion et al. Jun 2006 A1
20060149355 Mitelberg et al. Jul 2006 A1
20060155355 Jung Jul 2006 A1
20060173530 Das Aug 2006 A1
20060200230 Richter Sep 2006 A1
20060200234 Hines Sep 2006 A1
20060206199 Churchwell et al. Sep 2006 A1
20060217799 Mailander et al. Sep 2006 A1
20060224237 Furst et al. Oct 2006 A1
20060259123 Dorn Nov 2006 A1
20060265051 Caro et al. Nov 2006 A1
20060276877 Owens et al. Dec 2006 A1
20060276878 Owens et al. Dec 2006 A1
20060276879 Lye et al. Dec 2006 A1
20060287710 Lendlein et al. Dec 2006 A1
20070038288 Lye et al. Feb 2007 A1
20070083258 Falotico et al. Apr 2007 A1
20070088387 Eskridge et al. Apr 2007 A1
20070088425 Schaeffer Apr 2007 A1
20070112415 Bartlett May 2007 A1
20070150045 Ferrera Jun 2007 A1
20070173921 Wholey et al. Jul 2007 A1
20070213800 Fierens et al. Sep 2007 A1
20070276477 Lee et al. Nov 2007 A1
20070288083 Hines Dec 2007 A1
20080004653 Sherman et al. Jan 2008 A1
20090054966 Rudakov et al. Feb 2009 A1
Foreign Referenced Citations (38)
Number Date Country
0754435 Jan 1997 EP
0 864 301 Sep 1998 EP
0947204 Oct 1999 EP
1121911 Aug 2001 EP
1 129 666 Sep 2001 EP
1391184 Feb 2004 EP
1 470 795 Oct 2004 EP
1543798 Jun 2005 EP
1 550 477 Jul 2005 EP
1797844 Jun 2007 EP
1254623 Oct 1989 JP
WO 9814137 Apr 1998 WO
WO 9902092 Jan 1999 WO
WO 9958084 Nov 1999 WO
WO 9962432 Dec 1999 WO
WO 0001308 Jan 2000 WO
WO 00-06145 Feb 2000 WO
WO 0047134 Aug 2000 WO
WO 0051522 Sep 2000 WO
WO 0056247 Sep 2000 WO
WO 0166167 Sep 2001 WO
WO 0187184 Nov 2001 WO
WO 0193782 Dec 2001 WO
WO 0103607 Jan 2002 WO
WO 02-022024 Mar 2002 WO
WO 02-051336 Jul 2002 WO
WO 02069783 Sep 2002 WO
WO 02078764 Oct 2002 WO
WO 03049600 Jun 2003 WO
WO 03065881 Aug 2003 WO
WO 2004000379 Dec 2003 WO
WO 2004-028405 Apr 2004 WO
WO 2005000165 Jan 2005 WO
WO 2005-065580 Jul 2005 WO
WO 2005-086831 Sep 2005 WO
WO 2005094725 Oct 2005 WO
WO 2005094726 Oct 2005 WO
WO 2006033641 Mar 2006 WO
Non-Patent Literature Citations (2)
Entry
Chatterjee, S., Lactosylceramide stimulates aortic smooth muscle cell proliferation, Biochemical and Biophysical Research Communications, Dec. 16, 1991, 554-561, vol. 181, No. 2, Academic Press, Orlando, FL.
Reul, J. et al., Long-Term Angiographic and Histopathologic Findings in Experimental Aneurysms of the Carotid Bifurcation Embolized with Platinum and Tungsten Coils, American Journal of Neuroradiology, Jan. 1997, 35-42, vol. 18.
Related Publications (1)
Number Date Country
20070191924 A1 Aug 2007 US